Amy W Schulman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include FRACTYL HEALTH, INC., Zoetis Inc., ALNYLAM PHARMACEUTICALS, INC., PFIZER INC, BIND Therapeutics, Inc, Hudson Executive Investment Corp., Hudson Executive Investment Corp. II, IRONWOOD PHARMACEUTICALS INC, Blue Buffalo Pet Products, Inc., SQZ Biotechnologies Co, Cyclerion Therapeutics, Inc., Arsanis, Inc., Camp4 Therapeutics Corp, and Elevance Health, Inc..
2013 was Amy W Schulman's most active year for acquiring shares with 25 total transactions. Amy W Schulman's most active month to acquire stocks was the month of January. 2013 was Amy W Schulman's most active year for disposing of shares, totalling 19 transactions. Amy W Schulman's most active month to dispose stocks was the month of April. 2024 saw Amy W Schulman paying a total of $23,120,165.00 for 5,338,852 shares, this is the most they've acquired in one year. In 2012 Amy W Schulman cashed out on 218,990 shares for a total of $2,958,138.20, their largest year based on trade value.